Lorenzl S, Koedel U, Pfister H W
Neurologische Klinik, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, Germany.
Crit Care Med. 1996 Nov;24(11):1874-80. doi: 10.1097/00003246-199611000-00018.
To investigate the benefit of the hyperosmolar agent, mannitol, and the xanthine oxidase inhibitor, allopurinol, in experimental pneumococcal meningitis in the rat.
A prospective, randomized, controlled experimental study.
Experimental animal laboratory in a university hospital.
Sixty-five anesthetized and artificially ventilated adult male Wistar rats, weighing 250 to 300 g.
Meningitis was induced by intracisternal injection of live pneumococci. Infected rats were randomized to receive mannitol or allopurinol.
There were marked increases in regional cerebral blood flow (measured by laser-Doppler flowmetry), intracranial pressure, brain water content, and cerebrospinal fluid white blood cell count in infected rats within 6 hrs after infection (p < .05, compared with uninfected controls). Continuous infusion of mannitol (0.6 g/kg/hr iv), started just before infection, attenuated the increases of regional cerebral blood flow, intracranial pressure, and brain water content (p < .05, compared with untreated infected rats 6 hrs after infection). When continuous mannitol treatment was started 4 hrs after infection, intracranial pressure at 6 hrs was significantly lower than in untreated infected rats. When mannitol was given by a bolus injection (1.5 g/ kg iv) at 4 hrs after infection, intracranial pressure measured 0.5 hr thereafter was consistently reduced in all animals (intracranial pressure reduction by 21.3 +/- 5.1 [SEM]%). Pretreatment with allopurinol (150 mg/kg iv) did not significantly influence regional cerebral blood flow, intracranial pressure, and brain water content in pneumococci-injected rats. Both agents, mannitol and allopurinol, did not inhibit cerebrospinal fluid pleocytosis in infected rats. In uninfected rats, mannitol significantly increased regional cerebral blood flow by a nitric oxide-independent mechanism, whereas allopurinol slightly decreased blood flow.
Mannitol attenuated pathophysiologic changes in experimental pneumococcal meningitis. One possible mechanism of the mannitol effect might be scavenging of hydroxyl radicals which have been shown to be involved in the pathophysiology of pneumococcal meningitis. The failure of allopurinol to modulate pathophysiologic parameters may suggest that during early experimental pneumococcal meningitis in the rat, the xanthine oxidase pathway seems not to be a major source of reactive oxygen species.
研究高渗剂甘露醇和黄嘌呤氧化酶抑制剂别嘌醇在大鼠实验性肺炎球菌性脑膜炎中的作用。
一项前瞻性、随机、对照实验研究。
一所大学医院的实验动物实验室。
65只体重250至300克、经麻醉并进行人工通气的成年雄性Wistar大鼠。
通过脑池内注射活的肺炎球菌诱导脑膜炎。将感染的大鼠随机分为接受甘露醇或别嘌醇治疗组。
感染后6小时内,感染大鼠的局部脑血流量(通过激光多普勒血流仪测量)、颅内压、脑含水量和脑脊液白细胞计数显著增加(与未感染的对照组相比,p < 0.05)。在感染前开始持续静脉输注甘露醇(0.6克/千克/小时),可减轻局部脑血流量、颅内压和脑含水量的增加(与感染后6小时未治疗的感染大鼠相比,p < 0.05)。当在感染后4小时开始持续甘露醇治疗时,6小时时的颅内压显著低于未治疗的感染大鼠。当在感染后4小时通过大剂量注射(1.5克/千克静脉注射)给予甘露醇时,此后0.5小时测量的颅内压在所有动物中均持续降低(颅内压降低21.3 +/- 5.1 [标准误]%)。别嘌醇(150毫克/千克静脉注射)预处理对注射肺炎球菌的大鼠的局部脑血流量、颅内压和脑含水量没有显著影响。甘露醇和别嘌醇均未抑制感染大鼠脑脊液中的细胞增多。在未感染的大鼠中,甘露醇通过一种不依赖一氧化氮的机制显著增加局部脑血流量,而别嘌醇则使血流量略有降低。
甘露醇减轻了实验性肺炎球菌性脑膜炎的病理生理变化。甘露醇作用的一种可能机制可能是清除已被证明参与肺炎球菌性脑膜炎病理生理过程的羟自由基。别嘌醇未能调节病理生理参数可能表明,在大鼠早期实验性肺炎球菌性脑膜炎期间,黄嘌呤氧化酶途径似乎不是活性氧的主要来源。